U.S. Markets closed

The Best and Worst Big Biotech Stocks, According to One Analyst

Josh Nathan-Kazis

Credit Suisse’s Evan Seigerman gives a thumbs up to Vertex Pharmaceuticals and a thumbs down to Biogen.